Cadila approves merger of its 3 subsidiaries with itself

23 Apr 2013 Evaluate

Cadila Healthcare has approved the merger of Zydus Animal Health (ZAHL), Liva Healthcare (LHL) and Zydus Pharmaceuticals (ZPL) with itself. Gujarat based pharmaceutical company’s board and the Board of Directors of ZAHL, LHL and ZPL have reached the conclusion at their respective meetings held on April 22.

In terms of the Scheme ZAHL, LHL and ZPL will be amalgamated with the Cadila Healthcare followed by the dissolution without winding up of the ZAHL, LHL and ZPL. Upon the Scheme being effective, in consideration of the transfer and vesting of the undertaking of ZAHL, LHL and ZPL (the transferor Company) in the Company in terms of the Scheme, all the equity shares issued by the Transferor Companies and held by the Company and its nominees shall stand cancelled and extinguished and in lieu thereof, no allotment of any shares in the Company shall be made.

The flagship company of Zydus Cadila Group, focuses on various areas, such as formulations (human and veterinary), new drug discovery, novel drug delivery, pharmaceutical ingredients, analytical research, phytochemistry, biotechnology, plant tissue culture, etc.

 

Zydus Lifesciences Share Price

1058.45 15.00 (1.44%)
07-Jun-2024 15:40 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1507.00
Dr. Reddys Lab 6037.55
Cipla 1497.30
Zydus Lifesciences 1058.45
Lupin 1630.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.